A luciferin analogue generating near-infrared bioluminescence achieves highly sensitive deep-tissue imaging.
A luciferin analogue generating near-infrared bioluminescence achieves highly sensitive deep-tissue imaging.
复制标题
DOI:
10.1038/ncomms11856
复制
发表时间:
2016-06-14
影响因子:
16.6
通讯作者:
Kizaka-Kondoh S
中科院分区:
文献类型:
--
作者:
Kuchimaru T;Iwano S;Kiyama M;Mitsumata S;Kadonosono T;Niwa H;Maki S;Kizaka-Kondoh S
In preclinical cancer research, bioluminescence imaging with firefly luciferase and D-luciferin has become a standard to monitor biological processes both in vitro and in vivo. However, the emission maximum (λmax) of bioluminescence produced by D-luciferin is 562 nm where light is not highly penetrable in biological tissues. This emphasizes a need for developing a red-shifted bioluminescence imaging system to improve detection sensitivity of targets in deep tissue. Here we characterize the bioluminescent properties of the newly synthesized luciferin analogue, AkaLumine-HCl. The bioluminescence produced by AkaLumine-HCl in reactions with native firefly luciferase is in the near-infrared wavelength ranges (λmax=677 nm), and yields significantly increased target-detection sensitivity from deep tissues with maximal signals attained at very low concentrations, as compared with D-luciferin and emerging synthetic luciferin CycLuc1. These characteristics offer a more sensitive and accurate method for non-invasive bioluminescence imaging with native firefly luciferase in various animal models. D-luciferin is the standard bioluminescent substrate for in vitro and in vivo imaging. Here the authors introduce AkaLumine-HCl, a soluble luciferin analogue with a near-infrared emission maximum, which allows deep tissue imaging at lower concentrations than D-luciferin.